var eventsData = [{"Ticker":"CTAS","EffectiveDate":"2016-12-22","Type":"EarningsRelease","Title":"After market close, CTAS reports 2017 Q2's earning $1.15 per share and revenue $1297MM. This meets analyst's estimated EPS $1.15, beats estimated revenue $1290MM.","DailyReturn":"0.48%","FiveDayReturnAfter":"-2.7%","FiveDayReturnBefore":"-0.01%"},{"Ticker":"CTAS","EffectiveDate":"2016-11-02","Type":"Dividend","Title":"The Firm pays dividend $1.33","DailyReturn":"-0.44%","FiveDayReturnAfter":"2.49%","FiveDayReturnBefore":"-2.24%"},{"Ticker":"CTAS","EffectiveDate":"2016-10-18","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.13%","FiveDayReturnAfter":"-1.18%","FiveDayReturnBefore":"-2.31%"},{"Ticker":"CTAS","EffectiveDate":"2016-10-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.13%","FiveDayReturnAfter":"-1.18%","FiveDayReturnBefore":"-2.31%"},{"Ticker":"CTAS","EffectiveDate":"2016-10-18","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.13%","FiveDayReturnAfter":"-1.18%","FiveDayReturnBefore":"-2.31%"},{"Ticker":"CTAS","EffectiveDate":"2016-10-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.39%","FiveDayReturnAfter":"-0.84%","FiveDayReturnBefore":"-1.95%"},{"Ticker":"CTAS","EffectiveDate":"2016-10-03","Type":"RatingNeutral","Title":"KeyBanc maintains CTAS to Overweight. Target Price is $135; previously $130.","DailyReturn":"-0.15%","FiveDayReturnAfter":"-1.91%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"CTAS","EffectiveDate":"2016-09-29","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-4.14%","FiveDayReturnAfter":"-4.62%","FiveDayReturnBefore":"1.26%"},{"Ticker":"CTAS","EffectiveDate":"2016-09-27","Type":"EarningsRevenueBeat","Title":"After market close, CTAS reports 2017 Q1's earning $1.26 per share and revenue $1294MM. This beats analyst's estimated EPS $1.08, beats estimated revenue $1280MM.","DailyReturn":"0.21%","FiveDayReturnAfter":"-0.68%","FiveDayReturnBefore":"-0.11%"},{"Ticker":"CTAS","EffectiveDate":"2016-09-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.21%","FiveDayReturnAfter":"-0.68%","FiveDayReturnBefore":"-0.11%"},{"Ticker":"CTAS","EffectiveDate":"2016-09-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.21%","FiveDayReturnAfter":"-0.68%","FiveDayReturnBefore":"-0.11%"},{"Ticker":"CTAS","EffectiveDate":"2016-09-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.67%","FiveDayReturnAfter":"0.88%","FiveDayReturnBefore":"-2.68%"},{"Ticker":"CTAS","EffectiveDate":"2016-09-16","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-0.67%","FiveDayReturnAfter":"0.88%","FiveDayReturnBefore":"-2.68%"},{"Ticker":"CTAS","EffectiveDate":"2016-09-16","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.67%","FiveDayReturnAfter":"0.88%","FiveDayReturnBefore":"-2.68%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-26","Type":"RatingNeutral","Title":"Nomura maintains CTAS to Buy. Target Price is $135; previously $124.","DailyReturn":"-0.28%","FiveDayReturnAfter":"1.42%","FiveDayReturnBefore":"1.87%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-25","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CTAS to Neutral. Target Price is $130.","DailyReturn":"1.38%","FiveDayReturnAfter":"2.63%","FiveDayReturnBefore":"-1.04%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-17","Type":"RatingUpgrade","Title":"Barclays upgrades CTAS to Overweight from Equal-Weight. Target Price is $130; previously $110.","DailyReturn":"2.35%","FiveDayReturnAfter":"1.35%","FiveDayReturnBefore":"5.61%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-17","Type":"RatingNeutral","Title":"Morgan Stanley maintains CTAS to Underweight. Target Price is $80; previously $75.","DailyReturn":"2.35%","FiveDayReturnAfter":"1.35%","FiveDayReturnBefore":"5.61%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-17","Type":"RatingNeutral","Title":"KeyBanc maintains CTAS to Overweight. Target Price is $130; previously $110.","DailyReturn":"2.35%","FiveDayReturnAfter":"1.35%","FiveDayReturnBefore":"5.61%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-17","Type":"RatingUpgrade","Title":"Baird upgrades CTAS to Outperform from Neutral.","DailyReturn":"2.35%","FiveDayReturnAfter":"1.35%","FiveDayReturnBefore":"5.61%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-17","Type":"RatingNeutral","Title":"Nomura maintains CTAS to Buy. Target Price is $124; previously $107.","DailyReturn":"2.35%","FiveDayReturnAfter":"1.35%","FiveDayReturnBefore":"5.61%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-15","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.06%","FiveDayReturnAfter":"5.82%","FiveDayReturnBefore":"0.42%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-15","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.06%","FiveDayReturnAfter":"5.82%","FiveDayReturnBefore":"0.42%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.06%","FiveDayReturnAfter":"5.82%","FiveDayReturnBefore":"0.42%"},{"Ticker":"CTAS","EffectiveDate":"2016-08-11","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $110; previously $105.","DailyReturn":"0.12%","FiveDayReturnAfter":"7.41%","FiveDayReturnBefore":"0.99%"},{"Ticker":"CTAS","EffectiveDate":"2016-07-20","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $105; previously $95.","DailyReturn":"9.67%","FiveDayReturnAfter":"10.67%","FiveDayReturnBefore":"-0.08%"},{"Ticker":"CTAS","EffectiveDate":"2016-07-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.23%","FiveDayReturnAfter":"10.27%","FiveDayReturnBefore":"-0.42%"},{"Ticker":"CTAS","EffectiveDate":"2016-07-19","Type":"EarningsRevenueBeat","Title":"After market close, CTAS reports 2016 Q4's earning $1.08 per share and revenue $1271MM. This beats analyst's estimated EPS $1, beats estimated revenue $1250MM.","DailyReturn":"-0.23%","FiveDayReturnAfter":"10.27%","FiveDayReturnBefore":"-0.42%"},{"Ticker":"CTAS","EffectiveDate":"2016-07-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.23%","FiveDayReturnAfter":"10.27%","FiveDayReturnBefore":"-0.42%"},{"Ticker":"CTAS","EffectiveDate":"2016-06-23","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"1.15%","FiveDayReturnAfter":"1.1%","FiveDayReturnBefore":"0.59%"},{"Ticker":"CTAS","EffectiveDate":"2016-06-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.15%","FiveDayReturnAfter":"1.1%","FiveDayReturnBefore":"0.59%"},{"Ticker":"CTAS","EffectiveDate":"2016-06-23","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"1.15%","FiveDayReturnAfter":"1.1%","FiveDayReturnBefore":"0.59%"},{"Ticker":"CTAS","EffectiveDate":"2016-04-19","Type":"RatingNeutral","Title":"Nomura initiates coverage on CTAS to Buy. Target Price is $102.","DailyReturn":"0.17%","FiveDayReturnAfter":"-0.94%","FiveDayReturnBefore":"1.33%"},{"Ticker":"CTAS","EffectiveDate":"2016-04-13","Type":"RatingUpgrade","Title":"KeyBanc upgrades CTAS to Overweight from Sector Weight.","DailyReturn":"0.84%","FiveDayReturnAfter":"0.7%","FiveDayReturnBefore":"1.67%"},{"Ticker":"CTAS","EffectiveDate":"2016-03-22","Type":"RatingNeutral","Title":"Sterne Agee CRT initiates coverage on CTAS to Neutral.","DailyReturn":"0.18%","FiveDayReturnAfter":"-0.58%","FiveDayReturnBefore":"0.75%"},{"Ticker":"CTAS","EffectiveDate":"2016-03-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.18%","FiveDayReturnAfter":"-0.58%","FiveDayReturnBefore":"0.75%"},{"Ticker":"CTAS","EffectiveDate":"2016-03-22","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.18%","FiveDayReturnAfter":"-0.58%","FiveDayReturnBefore":"0.75%"},{"Ticker":"CTAS","EffectiveDate":"2016-02-17","Type":"RatingNeutral","Title":"Morgan Stanley downgrades CTAS to Underweight from Equal-Weight. Target Price is $79; previously $93.","DailyReturn":"-0.45%","FiveDayReturnAfter":"-0.02%","FiveDayReturnBefore":"1.6%"},{"Ticker":"CTAS","EffectiveDate":"2015-12-22","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $95; previously $90.","DailyReturn":"2.15%","FiveDayReturnAfter":"3.96%","FiveDayReturnBefore":"-0.78%"},{"Ticker":"CTAS","EffectiveDate":"2015-12-21","Type":"EarningsRevenueBeat","Title":"After market close, CTAS reports 2016 Q2's earning $1.03 per share and revenue $1219MM. This beats analyst's estimated EPS $1, beats estimated revenue $1210MM.","DailyReturn":"0.8%","FiveDayReturnAfter":"3.9%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"CTAS","EffectiveDate":"2015-12-21","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.8%","FiveDayReturnAfter":"3.9%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"CTAS","EffectiveDate":"2015-12-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.8%","FiveDayReturnAfter":"3.9%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"CTAS","EffectiveDate":"2015-11-04","Type":"Dividend","Title":"The Firm pays dividend $1.05","DailyReturn":"0.07%","FiveDayReturnAfter":"-0.12%","FiveDayReturnBefore":"-0.2%"},{"Ticker":"CTAS","EffectiveDate":"2015-10-14","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.85%","FiveDayReturnAfter":"1.42%","FiveDayReturnBefore":"6.45%"},{"Ticker":"CTAS","EffectiveDate":"2015-10-01","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"-0.3%","FiveDayReturnAfter":"1.83%","FiveDayReturnBefore":"-0.96%"},{"Ticker":"CTAS","EffectiveDate":"2015-10-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.3%","FiveDayReturnAfter":"1.83%","FiveDayReturnBefore":"-0.96%"},{"Ticker":"CTAS","EffectiveDate":"2015-09-25","Type":"RatingNeutral","Title":"Bank of America maintains CTAS to Underperform. Target Price is $82; previously $80.","DailyReturn":"2.61%","FiveDayReturnAfter":"-0.76%","FiveDayReturnBefore":"-0.56%"},{"Ticker":"CTAS","EffectiveDate":"2015-09-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.49%","FiveDayReturnAfter":"-0.96%","FiveDayReturnBefore":"0.28%"},{"Ticker":"CTAS","EffectiveDate":"2015-09-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.49%","FiveDayReturnAfter":"-0.96%","FiveDayReturnBefore":"0.28%"},{"Ticker":"CTAS","EffectiveDate":"2015-08-14","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on CTAS to Equal-Weight. Target Price is $92.","DailyReturn":"0.45%","FiveDayReturnAfter":"-1.7%","FiveDayReturnBefore":"0.99%"},{"Ticker":"CTAS","EffectiveDate":"2015-07-16","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.81%","FiveDayReturnAfter":"0.99%","FiveDayReturnBefore":"2.75%"},{"Ticker":"CTAS","EffectiveDate":"2015-07-16","Type":"EarningsBeatRevenueMiss","Title":"After market close, CTAS reports 2015 Q4's earning $0.86 per share and revenue $1143MM. This beats analyst's estimated EPS $0.84, misses estimated revenue $1150MM.","DailyReturn":"0.81%","FiveDayReturnAfter":"0.99%","FiveDayReturnBefore":"2.75%"},{"Ticker":"CTAS","EffectiveDate":"2015-07-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.81%","FiveDayReturnAfter":"0.99%","FiveDayReturnBefore":"2.75%"},{"Ticker":"CTAS","EffectiveDate":"2015-07-15","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.23%","FiveDayReturnAfter":"-1.27%","FiveDayReturnBefore":"1.8%"},{"Ticker":"CTAS","EffectiveDate":"2015-03-20","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $85; previously $80.","DailyReturn":"-1.67%","FiveDayReturnAfter":"-3.42%","FiveDayReturnBefore":"1.31%"},{"Ticker":"CTAS","EffectiveDate":"2015-03-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.05%","FiveDayReturnAfter":"-1.81%","FiveDayReturnBefore":"4.16%"},{"Ticker":"CTAS","EffectiveDate":"2015-03-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.05%","FiveDayReturnAfter":"-1.81%","FiveDayReturnBefore":"4.16%"},{"Ticker":"CTAS","EffectiveDate":"2014-12-22","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $80; previously $74.","DailyReturn":"0.51%","FiveDayReturnAfter":"0.42%","FiveDayReturnBefore":"10.92%"},{"Ticker":"CTAS","EffectiveDate":"2014-12-22","Type":"RatingNeutral","Title":"Jefferies maintains CTAS to Buy. Target Price is $90; previously $75.","DailyReturn":"0.51%","FiveDayReturnAfter":"0.42%","FiveDayReturnBefore":"10.92%"},{"Ticker":"CTAS","EffectiveDate":"2014-12-19","Type":"RatingNeutral","Title":"JP Morgan maintains CTAS to Overweight. Target Price is $84; previously $72.","DailyReturn":"6.36%","FiveDayReturnAfter":"6.91%","FiveDayReturnBefore":"2.29%"},{"Ticker":"CTAS","EffectiveDate":"2014-12-19","Type":"RatingNeutral","Title":"Bank of America maintains CTAS to Underperform. Target Price is $70; previously $60.","DailyReturn":"6.36%","FiveDayReturnAfter":"6.91%","FiveDayReturnBefore":"2.29%"},{"Ticker":"CTAS","EffectiveDate":"2014-12-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.26%","FiveDayReturnAfter":"9.2%","FiveDayReturnBefore":"1.34%"},{"Ticker":"CTAS","EffectiveDate":"2014-12-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.26%","FiveDayReturnAfter":"9.2%","FiveDayReturnBefore":"1.34%"},{"Ticker":"CTAS","EffectiveDate":"2014-12-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.03%","FiveDayReturnAfter":"1.41%","FiveDayReturnBefore":"-0.66%"},{"Ticker":"CTAS","EffectiveDate":"2014-11-05","Type":"Dividend","Title":"The Firm pays dividend $1.7","DailyReturn":"0.98%","FiveDayReturnAfter":"1.96%","FiveDayReturnBefore":"-0.54%"},{"Ticker":"CTAS","EffectiveDate":"2014-10-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"3.07%","FiveDayReturnAfter":"3.16%","FiveDayReturnBefore":"2.35%"},{"Ticker":"CTAS","EffectiveDate":"2014-10-21","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"3.07%","FiveDayReturnAfter":"3.16%","FiveDayReturnBefore":"2.35%"},{"Ticker":"CTAS","EffectiveDate":"2014-10-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.07%","FiveDayReturnAfter":"3.16%","FiveDayReturnBefore":"2.35%"},{"Ticker":"CTAS","EffectiveDate":"2014-09-30","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $68; previously $65.","DailyReturn":"7.03%","FiveDayReturnAfter":"5.81%","FiveDayReturnBefore":"-1.71%"},{"Ticker":"CTAS","EffectiveDate":"2014-09-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.48%","FiveDayReturnAfter":"5.96%","FiveDayReturnBefore":"-1.33%"},{"Ticker":"CTAS","EffectiveDate":"2014-09-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.48%","FiveDayReturnAfter":"5.96%","FiveDayReturnBefore":"-1.33%"},{"Ticker":"CTAS","EffectiveDate":"2014-09-15","Type":"RatingNeutral","Title":"Jefferies maintains CTAS to Buy. Target Price is $75; previously $70.","DailyReturn":"0.79%","FiveDayReturnAfter":"1.22%","FiveDayReturnBefore":"-0.48%"},{"Ticker":"CTAS","EffectiveDate":"2014-07-17","Type":"RatingNeutral","Title":"JP Morgan maintains CTAS to Overweight. Target Price is $69; previously $65.","DailyReturn":"-1.64%","FiveDayReturnAfter":"-0.74%","FiveDayReturnBefore":"1.38%"},{"Ticker":"CTAS","EffectiveDate":"2014-07-15","Type":"EarningsBeatRevenueMiss","Title":"After market close, CTAS reports 2014 Q4's earning $0.76 per share and revenue $1160MM. This beats analyst's estimated EPS $0.75, misses estimated revenue $1170MM.","DailyReturn":"-0.61%","FiveDayReturnAfter":"0.83%","FiveDayReturnBefore":"-1.02%"},{"Ticker":"CTAS","EffectiveDate":"2014-07-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.61%","FiveDayReturnAfter":"0.83%","FiveDayReturnBefore":"-1.02%"},{"Ticker":"CTAS","EffectiveDate":"2014-07-15","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.61%","FiveDayReturnAfter":"0.83%","FiveDayReturnBefore":"-1.02%"},{"Ticker":"CTAS","EffectiveDate":"2014-05-29","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"0.46%","FiveDayReturnBefore":"2.07%"},{"Ticker":"CTAS","EffectiveDate":"2014-05-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"0.46%","FiveDayReturnBefore":"2.07%"},{"Ticker":"CTAS","EffectiveDate":"2014-04-30","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.39%","FiveDayReturnAfter":"1.48%","FiveDayReturnBefore":"0.55%"},{"Ticker":"CTAS","EffectiveDate":"2014-03-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.06%","FiveDayReturnAfter":"-1.35%","FiveDayReturnBefore":"-0.23%"},{"Ticker":"CTAS","EffectiveDate":"2014-03-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.06%","FiveDayReturnAfter":"-1.35%","FiveDayReturnBefore":"-0.23%"},{"Ticker":"CTAS","EffectiveDate":"2014-03-18","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.95%","FiveDayReturnAfter":"-0.85%","FiveDayReturnBefore":"-1.97%"},{"Ticker":"CTAS","EffectiveDate":"2014-03-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.95%","FiveDayReturnAfter":"-0.85%","FiveDayReturnBefore":"-1.97%"},{"Ticker":"CTAS","EffectiveDate":"2014-01-21","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $65; previously $58.","DailyReturn":"1.2%","FiveDayReturnAfter":"-3.68%","FiveDayReturnBefore":"-0.23%"},{"Ticker":"CTAS","EffectiveDate":"2013-12-23","Type":"RatingNeutral","Title":"Credit Suisse maintains CTAS to Neutral. Target Price is $60; previously $56.","DailyReturn":"-0.42%","FiveDayReturnAfter":"0.3%","FiveDayReturnBefore":"6.78%"},{"Ticker":"CTAS","EffectiveDate":"2013-12-20","Type":"RatingNeutral","Title":"Bank of America maintains CTAS to Underperform. Target Price is $54; previously $46.","DailyReturn":"4.99%","FiveDayReturnAfter":"5.2%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CTAS","EffectiveDate":"2013-12-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"5.39%","FiveDayReturnBefore":"2.86%"},{"Ticker":"CTAS","EffectiveDate":"2013-12-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"5.39%","FiveDayReturnBefore":"2.86%"},{"Ticker":"CTAS","EffectiveDate":"2013-12-19","Type":"EarningsRevenueBeat","Title":"After market close, CTAS reports 2014 Q2's earning $0.7 per share and revenue $1140MM. This beats analyst's estimated EPS $0.68, beats estimated revenue $1120MM.","DailyReturn":"0.33%","FiveDayReturnAfter":"5.39%","FiveDayReturnBefore":"2.86%"},{"Ticker":"CTAS","EffectiveDate":"2013-12-16","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on CTAS to Neutral. Target Price is $56.","DailyReturn":"-0.63%","FiveDayReturnAfter":"6.78%","FiveDayReturnBefore":"1.05%"},{"Ticker":"CTAS","EffectiveDate":"2013-11-18","Type":"RatingNeutral","Title":"PiperJaffray initiates coverage on CTAS to Neutral. Target Price is $56.","DailyReturn":"-0.16%","FiveDayReturnAfter":"1.51%","FiveDayReturnBefore":"1.7%"},{"Ticker":"CTAS","EffectiveDate":"2013-11-06","Type":"Dividend","Title":"The Firm pays dividend $0.77","DailyReturn":"0.24%","FiveDayReturnAfter":"0.28%","FiveDayReturnBefore":"0.27%"},{"Ticker":"CTAS","EffectiveDate":"2013-10-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.07%","FiveDayReturnAfter":"1.04%","FiveDayReturnBefore":"2.79%"},{"Ticker":"CTAS","EffectiveDate":"2013-10-22","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.07%","FiveDayReturnAfter":"1.04%","FiveDayReturnBefore":"2.79%"},{"Ticker":"CTAS","EffectiveDate":"2013-10-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.07%","FiveDayReturnAfter":"1.04%","FiveDayReturnBefore":"2.79%"},{"Ticker":"CTAS","EffectiveDate":"2013-09-20","Type":"RatingNeutral","Title":"Barclays maintains CTAS to Equal-Weight. Target Price is $54; previously $50.","DailyReturn":"0.72%","FiveDayReturnAfter":"-0.01%","FiveDayReturnBefore":"2.36%"},{"Ticker":"CTAS","EffectiveDate":"2013-09-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.27%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"2.5%"},{"Ticker":"CTAS","EffectiveDate":"2013-09-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.27%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"2.5%"},{"Ticker":"CTAS","EffectiveDate":"2013-07-15","Type":"EarningsRelease","Title":"CTAS reports 2013 Q4's earning $0.69 per share and revenue $1130MM. This misses analyst's estimated EPS $0.7, meets estimated revenue $1130MM.","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.89%","FiveDayReturnBefore":"3.28%"},{"Ticker":"CTAS","EffectiveDate":"2013-07-15","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.89%","FiveDayReturnBefore":"3.28%"},{"Ticker":"CTAS","EffectiveDate":"2013-07-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.89%","FiveDayReturnBefore":"3.28%"},{"Ticker":"CTAS","EffectiveDate":"2013-07-02","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on CTAS to Outperform. Target Price is $52.","DailyReturn":"-0.06%","FiveDayReturnAfter":"3.33%","FiveDayReturnBefore":"1.23%"},{"Ticker":"CTAS","EffectiveDate":"2013-06-27","Type":"RatingNeutral","Title":"Jefferies maintains CTAS to Buy. Target Price is $52; previously $53.","DailyReturn":"1.1%","FiveDayReturnAfter":"0.94%","FiveDayReturnBefore":"-0.43%"},{"Ticker":"CTAS","EffectiveDate":"2013-05-30","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CTAS to Buy. Target Price is $53.","DailyReturn":"1.74%","FiveDayReturnAfter":"0.29%","FiveDayReturnBefore":"-2.58%"},{"Ticker":"CTAS","EffectiveDate":"2013-05-29","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CTAS to Buy. Target Price is $53.","DailyReturn":"-0.99%","FiveDayReturnAfter":"0.5%","FiveDayReturnBefore":"-1.6%"},{"Ticker":"CTAS","EffectiveDate":"2013-03-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.98%","FiveDayReturnAfter":"-5.44%","FiveDayReturnBefore":"2.38%"},{"Ticker":"CTAS","EffectiveDate":"2013-03-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.98%","FiveDayReturnAfter":"-5.44%","FiveDayReturnBefore":"2.38%"},{"Ticker":"CTAS","EffectiveDate":"2013-03-19","Type":"EarningsMissRevenueBeat","Title":"After market close, CTAS reports 2013 Q3's earning $0.6 per share and revenue $1080MM. This misses analyst's estimated EPS $0.61, beats estimated revenue $1060MM.","DailyReturn":"0.98%","FiveDayReturnAfter":"-5.44%","FiveDayReturnBefore":"2.38%"},{"Ticker":"CTAS","EffectiveDate":"2012-12-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.8%","FiveDayReturnAfter":"-4.2%","FiveDayReturnBefore":"1.59%"},{"Ticker":"CTAS","EffectiveDate":"2012-12-20","Type":"EarningsRelease","Title":"After market close, CTAS reports 2013 Q2's earning $0.63 per share and revenue $1060MM. This meets analyst's estimated EPS $0.63, meets estimated revenue $1060MM.","DailyReturn":"0.8%","FiveDayReturnAfter":"-4.2%","FiveDayReturnBefore":"1.59%"},{"Ticker":"CTAS","EffectiveDate":"2012-12-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.8%","FiveDayReturnAfter":"-4.2%","FiveDayReturnBefore":"1.59%"},{"Ticker":"CTAS","EffectiveDate":"2012-11-07","Type":"Dividend","Title":"The Firm pays dividend $0.64","DailyReturn":"0.09%","FiveDayReturnAfter":"-1.54%","FiveDayReturnBefore":"0.79%"},{"Ticker":"CTAS","EffectiveDate":"2012-10-16","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.4%","FiveDayReturnAfter":"0%","FiveDayReturnBefore":"-0.4%"},{"Ticker":"CTAS","EffectiveDate":"2012-10-16","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.4%","FiveDayReturnAfter":"0%","FiveDayReturnBefore":"-0.4%"},{"Ticker":"CTAS","EffectiveDate":"2012-09-24","Type":"RatingNeutral","Title":"Citigroup maintains CTAS to Buy. Target Price is $47; previously $45.","DailyReturn":"1.69%","FiveDayReturnAfter":"1.9%","FiveDayReturnBefore":"-2.59%"},{"Ticker":"CTAS","EffectiveDate":"2012-09-21","Type":"RatingNeutral","Title":"Citigroup maintains CTAS to Buy. Target Price is $47; previously $45.","DailyReturn":"-1.31%","FiveDayReturnAfter":"0.96%","FiveDayReturnBefore":"-2.46%"},{"Ticker":"CTAS","EffectiveDate":"2012-09-21","Type":"RatingNeutral","Title":"Bank of America maintains CTAS to Underperform. Target Price is $40; previously $37.","DailyReturn":"-1.31%","FiveDayReturnAfter":"0.96%","FiveDayReturnBefore":"-2.46%"},{"Ticker":"CTAS","EffectiveDate":"2012-09-21","Type":"RatingNeutral","Title":"JP Morgan maintains CTAS to Overweight. Target Price is $47; previously $46.","DailyReturn":"-1.31%","FiveDayReturnAfter":"0.96%","FiveDayReturnBefore":"-2.46%"},{"Ticker":"CTAS","EffectiveDate":"2012-09-20","Type":"EarningsBeatRevenueMiss","Title":"After market close, CTAS reports 2013 Q1's earning $0.6 per share and revenue $1050MM. This beats analyst's estimated EPS $0.59, misses estimated revenue $1060MM.","DailyReturn":"-0.16%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-1.44%"},{"Ticker":"CTAS","EffectiveDate":"2012-09-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.16%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-1.44%"},{"Ticker":"CTAS","EffectiveDate":"2012-09-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.16%","FiveDayReturnAfter":"-0.24%","FiveDayReturnBefore":"-1.44%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-30","Type":"RatingNeutral","Title":"Morgan Stanley maintains CTAS to Underweight. Target Price is $38; previously $32.","DailyReturn":"0.43%","FiveDayReturnAfter":"3.4%","FiveDayReturnBefore":"4.23%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.13%","FiveDayReturnAfter":"4.9%","FiveDayReturnBefore":"-4.78%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-24","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.13%","FiveDayReturnAfter":"4.9%","FiveDayReturnBefore":"-4.78%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-17","Type":"RatingNeutral","Title":"Barrington Research downgrades CTAS to Market Perform from Outperform.","DailyReturn":"-3.57%","FiveDayReturnAfter":"-4.78%","FiveDayReturnBefore":"0.61%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-17","Type":"RatingNeutral","Title":"Citigroup maintains CTAS to Buy. Target Price is $45; previously $47.","DailyReturn":"-3.57%","FiveDayReturnAfter":"-4.78%","FiveDayReturnBefore":"0.61%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-16","Type":"RevenueBeat","Title":"After market close, CTAS reports 2012 Q4's earning $0.6 per share and revenue $1050MM. This meets analyst's estimated EPS $0.6, misses estimated revenue $1070MM.","DailyReturn":"-1.15%","FiveDayReturnAfter":"-5.7%","FiveDayReturnBefore":"2.05%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.15%","FiveDayReturnAfter":"-5.7%","FiveDayReturnBefore":"2.05%"},{"Ticker":"CTAS","EffectiveDate":"2012-07-16","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.15%","FiveDayReturnAfter":"-5.7%","FiveDayReturnBefore":"2.05%"},{"Ticker":"CTAS","EffectiveDate":"2012-06-05","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.53%","FiveDayReturnAfter":"0.91%","FiveDayReturnBefore":"-4.1%"},{"Ticker":"CTAS","EffectiveDate":"2012-06-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.53%","FiveDayReturnAfter":"0.91%","FiveDayReturnBefore":"-4.1%"},{"Ticker":"CTAS","EffectiveDate":"2012-05-17","Type":"RatingNeutral","Title":"KeyBanc downgrades CTAS to Hold from Buy. Target Price is $43.","DailyReturn":"-2.77%","FiveDayReturnAfter":"-0.23%","FiveDayReturnBefore":"-1.85%"},{"Ticker":"CTAS","EffectiveDate":"2012-03-27","Type":"RatingNeutral","Title":"Morgan Stanley maintains CTAS to Underweight. Target Price is $32; previously $26.","DailyReturn":"-0.07%","FiveDayReturnAfter":"-1.36%","FiveDayReturnBefore":"-1.14%"},{"Ticker":"CTAS","EffectiveDate":"2012-03-21","Type":"RatingNeutral","Title":"Citigroup maintains CTAS to Buy. Target Price is $47; previously $46.","DailyReturn":"-3.13%","FiveDayReturnAfter":"-1.71%","FiveDayReturnBefore":"1.44%"},{"Ticker":"CTAS","EffectiveDate":"2012-03-21","Type":"RatingNeutral","Title":"Barrington Research maintains CTAS to Outperform. Target Price is $45; previously $41.","DailyReturn":"-3.13%","FiveDayReturnAfter":"-1.71%","FiveDayReturnBefore":"1.44%"},{"Ticker":"CTAS","EffectiveDate":"2012-03-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.49%","FiveDayReturnAfter":"-1.14%","FiveDayReturnBefore":"2.13%"},{"Ticker":"CTAS","EffectiveDate":"2012-03-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.49%","FiveDayReturnAfter":"-1.14%","FiveDayReturnBefore":"2.13%"},{"Ticker":"CTAS","EffectiveDate":"2012-03-14","Type":"RatingNeutral","Title":"Citigroup maintains CTAS to Buy. Target Price is $46; previously $38.","DailyReturn":"-0.97%","FiveDayReturnAfter":"1.44%","FiveDayReturnBefore":"6.01%"},{"Ticker":"CTAS","EffectiveDate":"2012-03-08","Type":"RatingUpgrade","Title":"JP Morgan upgrades CTAS to Overweight from Neutral. Target Price is $45; previously $34.","DailyReturn":"3.26%","FiveDayReturnAfter":"3.81%","FiveDayReturnBefore":"-1.41%"}];